NFKB1 and hypertensive disorder: SCFAs like butyrate and propionate offer multiple benefits: butyrate strengthens intestinal barriers by upregulating tight junction proteins, suppresses NF-κB-driven inflammation, and promotes Treg formation (62, 94), while propionate reduces HTN and systemic inflammation in preclinical models (95).